Skip to main content
search
Conference

ISPOR International Annual Conference 2026

Conference: ISPOR International Annual Conference 2026

Date: May 17 - 20, 2026

Location: Philadelphia, PA

Booth: 911

Best-in-class modeling paired with advanced analytics

Certara’s HEOR team is uniquely equipped to address the complexities of market access and value demonstration with precision and innovation. Our scientifically rigorous approaches ensure your product’s value resonates with healthcare decision-makers globally.

Certara poster presentations – more to be announced soon!

Monday, May 18th | 4:00pm-7:00pm
Discussion Period: 6:00pm-7:00pm
Poster Session 2: Translating Long term Risk Reduction With Ropeginterferon Alfa 2b Into Patient and Economic Impact in Polycythemia Vera
Monday, May 18th | 4:00pm-7:00pm
Discussion Period: 6:00pm-7:00pm
From Natural History to Post-Approval Evidence: An Integrated Multi-Source Real-World Program Characterizing IGA Nephropathy in the Era of Oral Targeted Release Formulation of Budesonide

Authors:
Lobat Hashemi, Veloxis Pharmaceuticals
Terri Madison, Calliditas Pharmaceuticals AB
Giancarlo Pesce, Certara

Explore our health economics and advanced modeling solutions

Explore our health economics and advanced modeling solutions

  • Health economic model design and programming – budget impact, cost-effectiveness analysis and value-based pricing models
  • Fit-for-purpose models – decision analytic, Markov and individual simulation approaches
  • Clinical trial analytics – advanced statistical modeling and curve-fitting methods
  • Indirect treatment comparisons – NMA, MAIC, ML-NMR and more
  • Bridging to effectiveness studies – combines predictive modeling with data analysis
  • Epidemiology forecasting models – patient flow and disease burden quantification
  • Systemic literature reviews – comprehensive, rigorous and HTA compliant
  • Local country adaptations – adaptation of global models for local submissions, e.g., AMCP, CADTH and more

Resources

Meet us there

Stop by booth #911 to connect with our experts and explore the latest advancements in HEOR, real-world evidence (RWE), and market access. From evidence generation to value demonstration, we help organizations navigate an increasingly complex landscape, where data, analytics, and strategy come together to inform better decisions and improve patient access.


Book your free 30-minute working session with a BaseCase SME

Not ready for a demo?

Skip the sales pitch. Book a 30-minute working session with a BaseCase SME and dive straight into your market access and value communication strategy.

You May Also Like

How to Leverage PBPK Modeling and Simulation in Drug Research and Development
How to Leverage PBPK Modeling and Simulation in Drug Research and DevelopmentGuide

How to Leverage PBPK Modeling and Simulation in Drug Research and Development

Best Practices for pharma commercialization in market access
Best Practices for pharma commercialization in market accessBlog

Best Practices for pharma commercialization in market access

Designing Drug Development Programs for Reimbursement Success
Designing Drug Development Programs for Reimbursement SuccessGuide

Designing Drug Development Programs for Reimbursement Success